In vivo monitoring of dihydroartemisinin-piperaquine sensitivity in Plasmodium falciparum along the China-Myanmar border of Yunnan Province, China from 2007 to 2013

BACKGROUND: Artemisinin-based combination therapy (ACT) is the recommended first-line treatment of falciparum malaria in all endemic countries. Artemisinin resistance in Plasmodium falciparum has been confirmed in the Greater Mekong subregion (GMS). Dihydroartemisinin-piperaquine (DAPQ) is the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hui, Yang, Heng-lin, Tang, Lin-hua, Li, Xing-liang, Huang, Fang, Wang, Jia-zhi, Li, Chun-fu, Wang, Heng-ye, Nie, Ren-hua, Guo, Xiang-rui, Lin, Ying-xue, Li, Mei, Wang, Jian, Xu, Jian-wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333884/
https://www.ncbi.nlm.nih.gov/pubmed/25652213
http://dx.doi.org/10.1186/s12936-015-0584-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333884/
https://www.ncbi.nlm.nih.gov/pubmed/25652213
http://dx.doi.org/10.1186/s12936-015-0584-8

Ejemplares similares